The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

INSULIN COMA THERAPY

A Study of Results in an Army Hospital
Published Online:https://doi.org/10.1176/ajp.111.6.466

Insulin coma therapy has been used at this hospital since October 1951. Up to June, 1954, 89 patients had received a full course of therapy. A very closely matched group of control patients was obtained, with following conclusions:

1. The insulin coma group showed essentially the same number of improved patients as the control group. Figures for the control group were actually slightly better.

2. The results in the group diagnosed catatonic schizophrenia were much better for the control group than for the insulin treated group. There was no difference in the other diagnostic categories.

3. Where EST was used it was at least as effective as insulin coma therapy.

4. Insulin does not increase the rate of improvement in patients diagnosed either acutely or chronically ill.

5. Although more severely ill patients are given insulin coma therapy, their improvement rate is the same as the control group.

It is our conclusion that the insulin coma therapy has been of little value in itself in the improvement of patients who have had it. We would venture to state that the results we have obtained, which only equal the results of a very similar group not getting insulin, were due to somatic and psychotherapeutic efforts simulataneous with the insulin coma therapy. Psychiatric hospitalization averaged 3 months longer per patient in the insulin group. Our conclusions do not warrant this excess period in the hospital.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.